These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 12115369)

  • 1. Evaluating a risk-based model for mammographic screening of women in their forties.
    McPherson CP; Nissen MJ
    Cancer; 2002 Jun; 94(11):2830-5. PubMed ID: 12115369
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk-based recommendations for mammographic screening for women in their forties.
    Gail M; Rimer B
    J Clin Oncol; 1998 Sep; 16(9):3105-14. PubMed ID: 9738582
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Screening mammography for women in their 40s: a retrospective study of the potential impact of the U.S. Preventive Service Task Force's 2009 breast cancer screening recommendations.
    Arleo EK; Dashevsky BZ; Reichman M; Babagbemi K; Drotman M; Rosenblatt R
    AJR Am J Roentgenol; 2013 Dec; 201(6):1401-6. PubMed ID: 24261383
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Mammographic screening with the assessment of risk factors and incidence of BRCA-associated breast cancer in the Republic of India].
    Ternovoĭ SK; Matkhev S; Meladze NV; Solopova AE; Abduraimov AB; Les'ko KA
    Vestn Rentgenol Radiol; 2012; (5):16-21. PubMed ID: 23516880
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence to Support Screening Women in Their 40s.
    Ray KM; Price ER; Joe BN
    Radiol Clin North Am; 2017 May; 55(3):429-439. PubMed ID: 28411671
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of mammography as a breast cancer screening tool in six districts in France.
    Lacour A; Mamelle N; Lafont S; Bazin B; Dubuc M; Exbrayat C; Trugeon A; Grosclaude P
    Cancer Detect Prev; 1997; 21(5):460-70. PubMed ID: 9307849
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Screening mammography: value in women 35-39 years old.
    Liberman L; Dershaw DD; Deutch BM; Thaler HT; Lippin BS
    AJR Am J Roentgenol; 1993 Jul; 161(1):53-6. PubMed ID: 8517320
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preventive health care, 2001 update: screening mammography among women aged 40-49 years at average risk of breast cancer.
    Ringash J;
    CMAJ; 2001 Feb; 164(4):469-76. PubMed ID: 11233866
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Breast cancer screening by mammography in women aged under 50 years in Japan.
    Morimoto T; Sasa M; Yamaguchi T; Kondo H; Akaiwa H; Sagara Y
    Anticancer Res; 2000; 20(5C):3689-94. PubMed ID: 11268440
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 'Weighing in' on screening mammography.
    Berz D; Sikov W; Colvin G; Weitzen S
    Breast Cancer Res Treat; 2009 Apr; 114(3):569-74. PubMed ID: 18491226
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NIH Consensus Statement. Breast cancer screening for women ages 40-49.
    NIH Consens Statement; 1997 Jan 21-23; 15(1):1-35. PubMed ID: 9267441
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biennial versus annual mammography and the risk of late-stage breast cancer.
    White E; Miglioretti DL; Yankaskas BC; Geller BM; Rosenberg RD; Kerlikowske K; Saba L; Vacek PM; Carney PA; Buist DS; Oestreicher N; Barlow W; Ballard-Barbash R; Taplin SH
    J Natl Cancer Inst; 2004 Dec; 96(24):1832-9. PubMed ID: 15601639
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factors contributing to mammography failure in women aged 40-49 years.
    Buist DS; Porter PL; Lehman C; Taplin SH; White E
    J Natl Cancer Inst; 2004 Oct; 96(19):1432-40. PubMed ID: 15467032
    [TBL] [Abstract][Full Text] [Related]  

  • 14. National Institutes of Health Consensus Development Conference Statement: breast cancer screening for women ages 40-49, January 21-23, 1997. National Institutes of Health Consensus Developmental Panel.
    J Natl Cancer Inst Monogr; 1997; (22):vii-xviii. PubMed ID: 9709265
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of patterns of hormone replacement therapy use and mammographic density on breast cancer detection.
    Chiarelli AM; Kirsh VA; Klar NS; Shumak R; Jong R; Fishell E; Yaffe MJ; Boyd NF
    Cancer Epidemiol Biomarkers Prev; 2006 Oct; 15(10):1856-62. PubMed ID: 17035392
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of lifetime gained as a result of mammographic breast cancer screening using a computer model.
    Jansen JT; Zoetelief J
    Br J Radiol; 1997 Jun; 70(834):619-28. PubMed ID: 9227256
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factors influencing breast density in Japanese women aged 40-49 in breast cancer screening mammography.
    Kawahara M; Sato S; Ida Y; Watanabe M; Fujishima M; Ishii H; Hori K; Kanazawa S
    Acta Med Okayama; 2013; 67(4):213-7. PubMed ID: 23970319
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mammographic screening in women at increased risk of breast cancer after treatment of Hodgkin's disease.
    Kwong A; Hancock SL; Bloom JR; Pal S; Birdwell RL; Mariscal C; Ikeda DM
    Breast J; 2008; 14(1):39-48. PubMed ID: 18186864
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mammographic screening of women aged 40 to 49 years. Is it justified?
    Feig SA
    Obstet Gynecol Clin North Am; 1994 Dec; 21(4):587-606. PubMed ID: 7731636
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of a mailed intervention on annual mammography and physician breast examinations among women at high risk of breast cancer.
    Richardson JL; Mondrus GT; Danley K; Deapen D; Mack T
    Cancer Epidemiol Biomarkers Prev; 1996 Jan; 5(1):71-6. PubMed ID: 8770470
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.